A Retrospective Chart Review Study of Patients With Chronic Lung Allograft Dysfunction-Bronchiolitis Obliterans Syndrome (CLAD-BOS) Post Lung Transplantation – "BOSTON EVOLUTION"

Study summary

No information provided.

Study identification

• EU PAS number:
  EUPAS1000001016
• Study ID:
  1000001016
• Official title and acronym:
  A Retrospective Chart Review Study of Patients With Chronic Lung Allograft Dysfunction-Bronchiolitis Obliterans Syndrome (CLAD-BOS) Post Lung Transplantation – "BOSTON EVOLUTION"
• DARWIN EU® study:
  No
• Study countries:
  Belgium

  Spain

  United States
• Study description:
  A retrospective, multinational, multicenter chart review study of adult patients with clinically diagnosed Chronic Lung Allograft Dysfunction-Bronchiolitis Obliterans Syndrome (CLAD-BOS) after lung transplantation. All data retrospectively collected from patient records starting from lung transplantation date through last date of available data.
• Study status:
  Finalised

Research institutions and networks

Institutions

Fortrea - Real world Intelligence & Late Phase Solution

Germany

United Kingdom (Northern Ireland)

Zambon

Study timelines

Date when funding contract was signed

Planned:30/11/2023

Actual:30/11/2023

Study start date

Planned:18/05/2024

Actual:27/06/2024

Data analysis start date

Planned:14/01/2025

Actual:12/05/2025

Date of final study report

Planned:15/04/2025

Actual:16/04/2026

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Zambon SpA, Via Lillo del Duca, 10 Bresso (MI) 20091 Italy

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable

Other study registration identification numbers and links

Protocol version identifier: Z8000N01